Leef Brands (LEEEF) Common Equity (2023 - 2026)
Leef Brands (LEEEF) reported Common Equity of -$5.7 million for Q1 2026, up 45.97% on a YoY basis from -$3.9 million in Q1 2025, and up 30.46% sequentially from -$8.3 million in Q4 2025.
Leef Brands (LEEEF) Common Equity (2023 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 4 years of Common Equity data on file, last reported at -$5.7 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 45.97% year-over-year to -$5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (up 45.97% YoY), and the FY2025 full-year result was -$8.3 million, up 33.5% from the prior year.
- Common Equity rose to -$5.7 million in Q1 2026, from -$8.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $847657.0 in Q4 2023 to a low of -$12.4 million in Q4 2024.
- A 4-year average of -$7.2 million and a median of -$8.3 million in 2025 frame the typical range for Common Equity.
- Across the five-year window, Common Equity sank 1566.86% in 2024 and surged 45.97% in 2026, its largest moves.
- Tracing LEEEF's Common Equity over 4 years: stood at $847657.0 in 2023, then slumped by 1566.86% to -$12.4 million in 2024, then soared by 33.5% to -$8.3 million in 2025, then jumped by 30.46% to -$5.7 million in 2026.
- Business Quant data shows LEEEF's Common Equity at -$5.7 million in Q1 2026, -$8.3 million in Q4 2025, and -$10.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | -5.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.75 Mn |
| Dec 31, 2025 | -8.27 Mn |
| Mar 31, 2025 | -10.64 Mn |
| Dec 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | 847,657.00 |